Learn more

INCELLDX INC

Overview
  • Total Patents
    45
  • GoodIP Patent Rank
    43,284
  • Filing trend
    ⇩ 80.0%
About

INCELLDX INC has a total of 45 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, computer technology and measurement are ADVANCED BIOMEDICAL LTD, MATSUMOTO TORU and TOHOKU DENSHI SANGYO KK.

Patent filings per year

Chart showing INCELLDX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Patterson Bruce K 34
#2 Chargin Amanda Noel 19
#3 Shults Keith 14
#4 Jafarianmohamady Seyedhamed 5
#5 Subramaniam Srividyabhuvaneswari 3
#6 Bruce K Patterson 2
#7 Rodrigues Hallison 2
#8 Pise Amruta 2
#9 Yin Fangfang 2
#10 Francisco Edgar B 2

Latest patents

Publication Filing date Title
US2020362044A1 Methods of Treating Cytokine Storm Infections, Including COVID-19, By Inhibiting CCR5/CCL5 (RANTES) Interaction, and Compositions for Practicing the Same
WO2020168244A1 Assaying bladder-associated samples, identifying and treating bladder-associated neoplasia, and kits for use therein
WO2020009988A1 Methods for detecting cancer-related cell populations, screening for metastatic cancer and treatments thereof
WO2018098440A1 Hiv phenotyping assay, methods, compositions and cells for practicing the same
EP3510378A1 Methods of detecting per cell pd-l1 expression and uses thereof
US2016349232A1 Methods of assessing cellular breast samples and compositions for use in practicing the same
WO2016014861A1 Methods of evaluating a cellular sample for latent cellular replication competent hiv-1, and compositions and kits for use in practicing the same
CN105122064A Methods for determining whether a cervical cellular sample should be tested for cervical cancer, and devices and kits for practicing the same
EP3217178A2 Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
EP2258877A2 HPV E6,E7 mRNA assay and methods of use thereof